Article Details

AstraZeneca Highlights First Results From Datopotamab Study In Pretreated Breast Cancer Patients

Retrieved on: 2022-12-09 12:47:35

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca Highlights First Results From Datopotamab Study In Pretreated Breast Cancer Patients. View article details on HISWAI: https://www.benzinga.com/general/biotech/22/12/30019095/astrazeneca-highlights-first-results-from-datopotamab-study-in-pretreated-breast-cancer-patients

Excerpt

AstraZeneca Plc · The data showed encouraging and durable efficacy in patients with heavily pretreated hormone receptor (HR)-positive, HER2-low, or ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up